Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):90–98. doi: 10.1097/QAI.0000000000002233

Table 1:

HIV-infected donor clinical characteristics.

Donor Blood Plasma (ml) Seminal Plasma (ml) Viral load (GE/ml) ARV Therapy CD4 count* ART yrs*
1 3 1.0 120,000 Therapy-naïve 39 N/A
2 3 1.0 34,000 Therapy-naïve 295 N/A
3 3 1.0 1,318,000 Therapy-naïve 6 N/A
4 3 0.6 35,000 Therapy-naïve 453 N/A
5 3 0.65 16,000 Therapy-naïve 489 N/A
6 4 1.2 ND ABC, 3TC, EFV 1,037 > 5
7 4 1.2 ND ABC, 3TC, DTG 545 > 5
8 4 0.9 ND TAF, FTC, DTG 944 > 5
9 3 1.0 ND ABC, 3TC, EFV 597 > 5
10 3 0.4 ND ABC, 3TC, EFV 568 > 5
11 3 0.6 ND ABC, 3TC, DTG 564 > 5
12 3 0.6 32 TAF, FTC, DTG 361 1
13 3 0.7 ND TAF, FTC, DTG 915 > 5
14 3 0.6 ND TDF, FTC, EFV 721 > 5
15 3 1.0 ND TAF, FTC, DRV/rit 395 > 5
16 3 1.0 ND TAF, FTC, DTG 416 0.17
17 3 1.0 ND TDF, FTC, EFV 1,159 > 5
18 3 1.0 ND ABC, 3TC, DTG 452 0.67

GE = genome equivalents; ARV – antiretroviral; CD4 count in cells/mm3; yrs = duration in years; NA = not applicable; ND = below limit of detection; ABC = abacavir; 3TC = lamivudine; EFV = efavirenz, DTG = dolutegravir, TAF = tenofovir alafenamide; FTC = emtrictabine; TDF = tenofovir disoproxil fumarate; DRV/r = ritonavir boosted darunavir